Patent · US Active

Sustained release formulation of nalbuphine

US9186330B2 · kind B2 · utility

1Cited by

34References

37Claims

0Family size

Assignee

ENDO PHARMACEUTICALS INC. · US

Inventors

Anand R. Baichwal · Wappingers Falls, US
Philip A. Goliber · Lasne, BE
Anthony E. Carpanzano · New Milford, US
Thomas Sciascia · Belmont, US
Donald Diehl, II · New Fairfield, US
Brian Vogler · North White Plains, US

Key dates

Filing date	Jun 30, 2014
Grant date	Nov 17, 2015
Priority date	—
Expiry date	Jun 30, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.